TLR-9 Activation of Marginal Zone B Cells in Lupus Mice Regulates Immunity Through Increased IL-10 Production (original) (raw)
References
Krieg AM: CpG DNA: A pathogenic factor in systemic lupus erythematosus. J Clin Immunol 15:284–292, 1995 Google Scholar
Deng GM, Nilsson IM, Verdrengh M, Collins LV, Tarkowski A: Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis. Nat Med 5:702–705, 1999 Google Scholar
Klinman D: Does activation of the innate immune system contribute to the development of rheumatoid arthritis? Arthritis Rheum 48:590–593, 2003 Google Scholar
Lenert P, Goeken A, Handwerger BS, Ashman RF: Innate immune responses in lupus-prone Palmerston North mice: Differential responses to LPS and bacterial DNA/CpG oligonucleotides. J Clin Immunol 23:202–213, 2003 Google Scholar
Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdorfer B, Giese T, et al.: Quantitative expression of Toll-like receptor 1–10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligonucleotides. J Immunol 168:4531–4537, 2002. Google Scholar
Rhee SH, Hwang D: Murine Toll-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NFkB and expression of the inducible cyclooxygenase. J Biol Chem 275:34035–34040, 2000 Google Scholar
Ogata H, Su I-H, Miyake K, Nagai Y, Akashi S, Mecklenbrauker I, et al.: The Toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells. J Exp Med 192:23–29, 2000 Google Scholar
Messina JP, Gilkeson GS, Pisetsky DS: Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. J Immunol 147:1759–1764, 1991 Google Scholar
Krieg AM, Yi A-K, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, et al.: CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374:546–549, 1995 ArticleCASPubMed Google Scholar
Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, et al.: A Toll-like receptor recognizes bacterial DNA. Nature 408:740–745, 2000 CASPubMed Google Scholar
Takeshita F, Leifer CA, Gursel I, Ishii KJ, Takeshita S, Gursel, M, et al.: Cutting edge: Role of Toll-like receptor 9 in CpG DNA-induced activation of human cells. J Immunol 167:3555–3558, 2001 Google Scholar
Bauer S, Kirschning CJ, Hacker H, Redecke V, Hausmann S, Akira S, et al.: Human TLR-9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci USA 98:9237–9242, 2001 Google Scholar
Massari P, Heneke P, Ho Y, Latz E, Golenbock DT, Wetzler LM: Cutting edge: Immune stimulation by neisserial porins is Toll-like receptor 2 and MyD88 dependent. J Immunol 168:1533–1537, 2002 CASPubMed Google Scholar
Hemmi H, Kaisho T, Takeuchi O, Sato S, Sanjo H, Hoshino K, et al.: Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 3:196–200, 2002 Google Scholar
Yi AK, Krieg AM: Rapid induction of mitogen-activated protein kinases by immune stimulatory CpG DNA. J Immunol 161:4493–4497, 1998 Google Scholar
Lenert P, Stunz L, Yi AK, Krieg AM, Ashman RF: CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal to NF-κ B activation. Antisense Nucleic Acid Drug Dev 11:247–256, 2001 Google Scholar
Yi AK, Chang M, Peckham DW, Krieg AM, Ashman RF: CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry. J Immunol 160:5898–5906, 1998 Google Scholar
Stunz LL, Lenert P, Peckham D, Yi A-K, Haxhinasto S, Chang M, et al.: Inhibitory oligonucleotides specifically block effects of stimulatory CpG oligonucleotides in B cells. Eur J Immunol 32:1212–1222, 2002 Google Scholar
Klinman DM, Yi A-K, Beaucage SL, Conover J, Krieg AM: CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12 and interferon γ. J Immunol 93:2879–2883, 1996 Google Scholar
Yi AK, Hornbeck P, Lafrenz DE, Krieg AM: CpG DNA rescue of murine B lymphoma cells from anti-IgM-induced growth arrest and programmed cell death is associated with increased expression of c-myc and bcl-xl. J Immunol 157:4918–4925, 1996 Google Scholar
Luzina IG, Knitzler RH, Atamas SP, Gause WC, Papadimitriou JC, Sztein MB, et al.: Vasculitis in the Palmerston North mouse model of lupus: Phenotype and cytokine production profile of infiltrating cells. Arthritis Rheum 42:561–568, 1999 Google Scholar
Ballas ZK, Rasmussen WL, Krieg AM: Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J Immunol 157:1840–1845, 1996 Google Scholar
Chase JH, Hooker NA, Mildenstein KL, Krieg AM, Cowdery JS: Bacterial DNA-induced NK cell IFN-γ production is dependent on macrophage secretion of IL-12. Clin Immunol Immunopathol 84:185–193, 1997 Google Scholar
Snapper C, Paul W: Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236:944–947, 1987 Google Scholar
Ozmen L, Roman D, Fountoulakis M, Schmidt R, Ryffel B, Garotta G: Experimental therapy of systemic lupus erythematosus: The treatment of NZB/NZW mice with mouse soluble interferon-g receptor inhibits the onset of glomerulonephritis. Eur J Immunol 25:6–12, 1995 Google Scholar
Lenert P, Rasmussen W, Ashman RF, Ballas ZK: Structural characterization of the inhibitory DNA motif for the type A(D)-CpG-induced cytokine secretion and NK-cell lytic activity in mouse spleen cells. DNA Cell Biol 22:621–631, 2003 Google Scholar
Gursel I, Gursel M, Yamada H, Ishii KJ, Takeshita F, Klinman DM: Repetitive elements in mammalian telomeres suppress bacterial DNA-induced immune activation. J Immunol 171:1393–1400, 2003 Google Scholar
Krug A, Rothenfusser S, Hornung V, Jahrsdorfer B, Blackwell S, Ballas ZK, et al.: Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmocytoid dendritic cells. Eur J Immunol 31:2154–2163, 2001 Google Scholar
Verthelyi D, Ishii KJ, Gursel M, Takeshita F, Klinman DM: Human peripheral blood cells differentially recognize and respond to two distinct CpG motifs. J Immunol 166:2372–2377, 2001 Google Scholar
Chesnut RW, Grey HM: Studies on the capacity of B cells to serve as antigen-presenting cells. J Immunol 126:1075–1079, 1981 Google Scholar
Lanzavecchia A: Antigen-specific interaction between T and B cells. Nature 314: 537–539, 1985 Google Scholar
Fuchs EJ, Matzinger P: B cells turn off virgin but not memory T cells. Science 258:1156–1159, 1992 Google Scholar
Constant S, Schweitzer N, West J, Ranney P, Bottomly K: B lymphocytes can be competent antigen-presenting cells for priming CD4+ T cells to protein antigens in vivo. J Immunol 155:3734–3741, 1995 Google Scholar
Constant SL: B lymphocytes as antigen-presenting cells for CD4+ T cell priming in vivo. J Immunol 162:5695–5703, 1999 Google Scholar
Paroli M, Accapezzato D, Insalaco A, Plebani A, Balsano F, Barnaba V: Long-lasting memory-resting and memory-effector CD4+ T cells in human X-linked agammaglobulinemia. Blood 99:2131–2137, 2002 Google Scholar
Epstein MM, Di Rosa F, Jankovic D, Sher A, Matzinger P: Successful T cell priming in B cell-deficient mice. J Exp Med 182:915–922, 1995 Google Scholar
Bosio CM, Gardner D, Elkins KL: Infection of B cell-deficient mice with CDC 1551, a clinical isolate of Mycobacterium tuberculosis: Delay in dissemination and development of lung pathology. J Immunol 164:6417–6425, 2000 Google Scholar
Graham MB, Braciale TJ: Resistance to and recovery from lethal influenza virus infection in B lymphocyte-deficient mice. J Exp Med 186:2063–2068, 1997 Google Scholar
Smelt SC, Cottereli SEJ, Engwarda CR, Kaye PM: B cell-deficient mice are highly resistant to Leishmania donovani infection, but develop neutrophil-mediated tissue pathology. J Immunol 164:3681–3688, 2000 Google Scholar
Moulin V, Andris F, Thielemans K, Maliszewski C, Urbain J, Moser M: B lymphocytes regulate dendritic cell (DC) function in vivo: Increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation. J Exp Med 192:475–482, 2000 Google Scholar
Cunningham AF, Fallon PG, Khan M, Vacheron S, Acha-Orbea H, MacLennan ICM, et al.: Th2 activities induced during virgin T cell priming in the absence of IL-4, IL-13, and B cells. J Immunol 169: 2900–2906, 2002 Google Scholar
Shen H, Whitmire JK, Fan X, Shedlock DJ, Kaech SM, Ahmed R: A specific role for B cells in the generation of CD8 T cell memory by recombinant Listeria monocytogenes. J Immunol 170:1443–1451, 2003 Google Scholar
Linton PJ, Harbertson J, Bradley LM: A critical role for B cells in the development of memory CD4 cells. J Immunol 165:5558–5565, 2000 Google Scholar
Tsitoura DC, Yeung VP, DeKuyff RH, Umetsu DT: Critical role of B cells in the development of T cell tolerance to aeroallergens. Int Immunol 14:659–667, 2002 Google Scholar
Roth R, Gee RJ, Mamula MJ: B lymphocytes as autoantigen-presenting cells in the amplification of autoimmunity. Ann NY Acad Sci 815:88–104, 1997 Google Scholar
Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 392:245–252, 1998 ArticleCASPubMed Google Scholar
Skok J, Poudrier J, Gray D: Dendritic cell-derived IL-12 promotes B cell induction of Th2 differentiation: A feedback regulation of Th1 development. J Immunol 163:4284–4291, 1999 Google Scholar
Jankovic D, Cheever AW, Kullberg MC, Wynn TA, Yap G, Caspar P, et al.: CD4+ T cell-mediated granulomatous pathology in schistosomiasis is downregulated by a B cell-dependent mechanism requiring Fc receptor signaling. J Exp Med 187:619–629, 1998 Google Scholar
Wolf SD, Dittel BN, Hardardottir F, Janeway CA Jr: Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med 184:2271–2278, 1996 Google Scholar
Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM: B cells regulate autoimmunity by provision of IL-10. Nat Immunol 3:944–950, 2002 Google Scholar
Vakkalanka RK, Woo C, Kirou KA, Koshy M, Berger D, Crow MK: Elevated levels and functional capacity of soluble CD40 ligand in systemic lupus erythematosus sera. Arthritis Rheum 42:871–881, 1999 Google Scholar
Xu LG, Shu HB: TNFR-associated factor-3 is associated with BAFF-R and negatively regulates BAFF-R-mediated NF-kB activation and IL-10 production. J Immunol 169:6883–6889, 2002 Google Scholar
Mackay F, Woodcock SA, Lawton AC, Baetscher M, Schneider P, Tschopp J, et al.: Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 190:1697–1710, 1999 Google Scholar
Yin Z, Bahtiyar GM, Zhang N, Liu L, Zhu P, Robert ME, et al.: IL-10 regulates murine lupus. J Immunol 169:2148–2155, 2002 Google Scholar
Leadbetter EA, Rifkin AR, Hohlbaum AM, Beaudette BC, Schlomchik MJ, Marshak-Rothstein A: Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416:603–607, 2002 Google Scholar
Gilkeson GS, Grudier JP, Karounos DG, Pisetsky DS: Induction of anti-double stranded DNA antibodies in normal mice by immunization with bacterial DNA. J Immunol 142:1482–1486, 1989 Google Scholar
Chen Y, Lenert P, Weeratna R, McCluskie M, Wu T, Davis HL, et al.: Identification of methylated CpG motifs as inhibitors of the immune stimulatory CpG motifs. Gene Ther 8:1024–1032, 2001 Google Scholar
Zeuner RA, Ishii KJ, Lizak MJ, Gursel I, Yamada H, Klinman DM, et al.: Reduction of CpG-induced arthritis by suppressive oligodeoxynucleotides. Arthritis Rheum 46:2219–2224, 2002 Google Scholar
Gilkeson GS, Ruiz P, Pippen AM, Alexander AL, Lefkowith JB, Pisetsky DS: Modulation of renal disease in autoimmune NZB/NZW mice by immunization with bacterial DNA. J Exp Med 183:1389–1397, 1996 Google Scholar
Anders HJ, Vielhauer V, Eis V, Linde Y, Kretzler M, de Lema GP, et al.: Activation of Toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice. FASEB J 18:534–536, 2004 Google Scholar
Hasegawa K, Hayashi T: Synthetic CpG oligodeoxynucleotides accelerate the development of lupus nephritis during preactive phase in NZBxNZW F1 mice. Lupus 12:838–845, 2003 Google Scholar
Liu J, Beller DI: Aberrant production of IL-12 by macrophages from several autoimmune-prone mouse strains is characterized by intrinsic and unique patterns of NF-κ B expression and binding to the IL-12 p40 promoter. J Immunol 169:581–586, 2002 Google Scholar
Liu J, Beller DI: Distinct pathways for NF-κ B regulation are associated with aberrant macrophage IL-12 production in lupus- and diabetes-prone mouse strains. J Immunol 170:4489–4496, 2003 Google Scholar
Wither JE, Roy V, Brennan LA: Activated B cells express increased levels of costimulatory molecules in young autoimmune NZB and (NZBxNZW)F(1) mice. Clin Immunol 94:51–63, 2000 Google Scholar
Chen X, Martin F, Forbush KA, Perlmutter RM, Kearney JF: Evidence of selection of a population of multireactive B cells into the splenic marginal zone. Int Immunol 9:27–41, 1997 Google Scholar
Kenny JJ, Rezanka LJ, Lustig A, Fischer RT, Yoder J, Marshall S, et al.: Autoreactive B cells escape clonal deletion by expressing multiple antigen receptors. J Immunol 164:4111–4119, 2000 Google Scholar
Li Y, Li H, Weigert M: Autoreactive B cells in the marginal zones that express dual receptors. J Exp Med 195:181–188, 2002 Google Scholar
Grimaldi CM, Michael DJ, Diamond B: Cutting Edge: Expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus. J Immunol 167:1886–1890, 2001 Google Scholar
Atencio S, Amano H, Izui S, Kotzin BL: Separation of the New Zealand Black genetic contribution to lupus from New Zealand Black determined expansions of marginal zone B and B1a cells. J Immunol 172: 4159–4166, 2004 Google Scholar